Phase I Testing of a Malaria Vaccine Composed of Hepatitis B Virus Core Particles Expressing Plasmodium falciparum Circumsporozoite Epitopes

We report the first phase I trial to assess the safety and immunogenicity of a malaria vaccine candidate, ICC-1132 (Malarivax), composed of a modified hepatitis B virus core protein (HBc) containing minimal epitopes of the Plasmodium falciparum circumsporozoite (CS) protein. When expressed in Escher...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Infect Immun
Main Authors: Nardin, Elizabeth H., Oliveira, Giane A., Calvo-Calle, J. Mauricio, Wetzel, Kristiane, Maier, Carolin, Birkett, Ashley J., Sarpotdar, Pramod, Corado, Michael L., Thornton, George B., Schmidt, Annette
Format: Artigo
Jezik:Inglês
Izdano: American Society for Microbiology (ASM) 2004
Teme:
Microbial Immunity and Vaccines
Online dostop:https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC523031/
https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/15501783/
https://ncbi.nlm.nih.govhttps://doi.org/10.1128/IAI.72.11.6519-6527.2004
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki